test

Manish Mital

@Braidwell Lp

Latest period2024 - Q3ReportedManaged Assets$3.528BTotal holdings81
Assets growth rate10.68%Assets growth rate (2-Q avg)6.71%Continuous growth in asset value3 quarters

Portfolio positions

This chart displays the top 10 holdings in Braidwell Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 81 positions.

Assets under management

The assets under management (AUM) of Braidwell Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 3 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 3.528B in assets, with a quarterly growth rate of 10.68% and a 2-quarter average growth rate of 6.71%. The portfolio is managed by Manish Mital, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
SRPTSarepta Therapeutics Inc
Recent Activity
Increased 352.26%
1.32%
$46.259M
370,400 shares@ $124.89 avg price
1080⤦Bridgebio Pharma Inc
Recent Activity
Decreased -18.29%
1.28%
$45.019M
53.594M shares@ $0.84 avg price
ISRGIntuitive Surgical Inc
Recent Activity
Decreased -9.15%
1.28%
$44.853M
91,300 shares@ $491.27 avg price
AVDLAvadel Pharmaceuticals Plc
Recent Activity
Increased 16.92%
1.26%
$44.446M
3.389M shares@ $13.12 avg price
BCAXBicara Therapeutics Inc
Recent Activity
New Position
1.2%
$42.219M
1.658M shares@ $25.47 avg price
KROSKeros Therapeutics Inc
Recent Activity
Decreased -27.99%
1.17%
$41.069M
707,240 shares@ $58.08 avg price
GKOSGlaukos Corp
Recent Activity
Decreased -37.24%
1.16%
$40.597M
311,616 shares@ $130.28 avg price
MDGLMadrigal Pharmaceuticals Inc
Recent Activity
New Position
1.11%
$39.01M
183,818 shares@ $212.23 avg price
PCVXVaxcyte Inc
Recent Activity
Decreased -63.18%
0.97%
$34.003M
297,568 shares@ $114.27 avg price
REPLReplimune Group Inc
Recent Activity
Increased 203.04%
0.96%
$33.656M
3.071M shares@ $10.97 avg price